Stoquity Living researchResearch LedgerSlicesMethodologyFor institutionsAbout
Stoquity Research Ledger

MSA Safety Incorporated (MSA)

NYSE: MSA · Orthopedic, Prosthetic & Surgical Appliances & Supplies · Cranberry Township, PA

Our rating: Neutral

Neutral reaffirmed at $177.60, moderate conviction, November 4, 2026.

Breaks if: The Neutral call tilts Positive if MSA reports revenue growth above 7% for two consecutive quarters, implying genuine end-market acceleration that would begin to justify the current 25× multiple with room to expand. It tilts Cautious if net income margin falls below 12% for two consecutive quarters — a compression of that magnitude would strip the valuation support and leave the multiple without an earnings underpinning at current prices.

Key figures

Market value$6.5B
Revenue, last 12 months$2.0B
Net income, last 12 months$303M
Free cash flow, last 12 months$322M
Price to earnings21.6×
Free cash flow yield4.9%
Dividend yield1.3%
Operating margin20.2%
Return on equity22.1%
Beta to the S&P 5000.77
Volatility, annualized24.2%

Reported quarters

Quarter endingRevenueYear on yearEarnings per shareFree cash flow
September 30, 2026$536M14.5%$1.51$68M
June 30, 2026$503M6.2%$2.23$83M
March 31, 2026$464M10.0%$1.83$65M
December 31, 2025$511M2.2%$2.21$106M
September 30, 2025$468M8.3%$1.77$100M
June 30, 2025$474M2.5%$1.59$38M
March 31, 2025$421M1.9%$1.51$51M
December 31, 2024$500M0.9%$2.22$93M

Three-model forecasts for the next quarter

Written November 21, 2026, before the report. Each settles from the SEC filing.

9 ledger entries and 37 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.